LAB: Labiana Health, S.A. - Summary | Jitta

Labiana Health, S.A.

ESP:LAB

Price
€6.30
Loss Chance
50.9%
3.13JITTA SCORE
137.90%Over Jitta Line
Jitta Ranking
61 / 143
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (48)
Recent Business Performance (53)
Financial Strength (32)
Return to Shareholders (25)
Competitive Advantage (44)
Jitta Signs
Operating MarginInconsistent
Recent Business PerformanceEarning decline 78.20% in the last year
Key Stats
Jitta Score
Jitta Line
3.13
137.90%
2.37
337.60%
2.37
337.60%
0.12
100.00%
3.33
> 1,000%
0.96
100.00%
COMPANY DESCRIPTION
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, and bacterial vaccines; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contract developments, quality system and manufacturing services. Labiana Health S.A. was founded in 1958 and is based in Pozuelo de Alarcón, Spain.